Biodel Announces Plans to Advance BIOD-531 Based on Positive Clinical Trial Results

[GlobeNewswire] – Phase 1 Clinical Trial Data Demonstrate that Biodel’s Concentrated Insulin BIOD-531 has a More Rapid Absorption and Onset of Action Versus Both Humulin(R) R U-500 and Humalog(R) Mix 75/25 and a Duration … more

View todays social media effects on BIOD

View the latest stocks trending across Twitter. Click to view dashboard

See who Biodel is hiring next, click here to view